Elevance Health, Inc.
ELV
$336.36
-$3.04-0.90%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.58% | 0.68% | |||
| Total Other Revenue | 3.44% | 8.16% | |||
| Total Revenue | 1.88% | 1.81% | |||
| Cost of Revenue | 3.91% | 3.95% | |||
| Gross Profit | -3.82% | -3.75% | |||
| SG&A Expenses | 3.52% | 0.07% | |||
| Depreciation & Amortization | 10.20% | -5.16% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.84% | 3.04% | |||
| Operating Income | -33.27% | -16.17% | |||
| Income Before Tax | -38.66% | -18.06% | |||
| Income Tax Expenses | -60.04% | -10.60% | |||
| Earnings from Continuing Operations | -31.94% | -20.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 300.00% | 0.00% | |||
| Net Income | -31.78% | -20.16% | |||
| EBIT | -33.27% | -16.17% | |||
| EBITDA | -28.84% | -14.26% | |||
| EPS Basic | -31.20% | -19.73% | |||
| Normalized Basic EPS | -37.95% | -17.63% | |||
| EPS Diluted | -31.09% | -19.67% | |||
| Normalized Diluted EPS | -37.90% | -17.56% | |||
| Average Basic Shares Outstanding | -0.84% | -0.53% | |||
| Average Diluted Shares Outstanding | -0.93% | -0.62% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.45% | 0.25% | |||